Related Experiment Video

Updated: Jun 5, 2026

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo
08:19

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on: July 20, 2019

CCN6 (WISP3): a new anti-cancer therapy?

Andrew Leask1

  • 1Departments of Dentistry and Physiology and Pharmacology, University of Western Ontario, Dental Sciences Building, London, ON N6A 5C1 Canada.

Journal of Cell Communication and Signaling
|January 15, 2011
PubMed

Insights

Targeting CCN6 (WISP3) may offer new breast cancer treatments. This protein is downregulated in aggressive breast cancers, potentially promoting tumor survival and indicating a novel therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • The CCN family of matricellular proteins plays a role in cancer development and progression.
  • Dysregulation of CCN proteins is observed in various cancers, suggesting their potential as therapeutic targets.

Purpose of the Study:

  • To investigate the role of CCN6 (WISP3) in aggressive breast cancers.
  • To explore CCN6 as a potential therapeutic target for breast cancer treatment.

Main Methods:

  • Analysis of CCN6 (WISP3) expression levels in aggressive breast cancer samples.
  • Correlation of CCN6 (WISP3) downregulation with tumor survival and aggressiveness.

Main Results:

  • CCN6 (WISP3) was found to be downregulated in aggressive breast cancers.
  • Downregulation of CCN6 (WISP3) is associated with the promotion of tumor survival.

Conclusions:

  • CCN6 (WISP3) downregulation is a significant event in aggressive breast cancer.
  • Targeting CCN6 (WISP3) represents a promising novel therapeutic strategy for breast cancer.
Keywords:
CCN proteinsCCN6CancerWISP3

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...